|Articles|February 1, 2000

Ace Inhibitors and Their Utilization in Managed Care
Volume 6
Issue 3 Suppl

The Impact of Angiotensin-Converting Enzyme Inhibitors on Managed Care: Economic, Clinical, and Humanistic Outcomes (Quiz)

Author(s)C.E. Reeder, RPh, PhD, Greta A. Gourley, PhD, PharmD, J. Doug Wurtzbacher, PharmD

Download PDF: The Impact of Angiotensin-Converting Enzyme Inhibitors on Managed Care: Economic, Clinical, and Humanistic Outcomes (Quiz)

Articles in this issue

over 26 years ago

Article

Participating Faculty

over 26 years ago

Article

Continuing Medical and Pharmacy Educational Objectives

over 26 years ago

Article

Glossary of Abbreviations

over 26 years ago

Article

Class Effects of Angiotensin-Converting Enzyme Inhibitors (Quiz)

over 26 years ago

Article

Case 1: Hypertension; Impaired Glucose Tolerance (Quiz)

over 26 years ago

Article

Case 2: Hypertension Therapy in Managed Care (Quiz)

over 26 years ago

Article

Case 3: Coronary Heart Disease; Hypertension

over 26 years ago

Article

Case 4: Systolic Hypertension; Diabetes Mellitus; Renal Dysfunction; and the Use of ACE Inhibitors in African-American Population

over 26 years ago

Article

Case 5: Congestive Heart Failure; Prior Myocardial Infarction; Economic Consideration of Care in Medicare Population

over 26 years ago

Article

Case 6: Alcoholic Cardiomyopathy; Hypertension

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

ByOnur Baser, PhD, MS,Heidi C. Waters, PhD,Nehir Yapar, BS,Gabriela Samayoa, MD, MPH,Xue Han, PhD,Deborah Freedman, MBA,Lauren Isenman, MPH,Rashmi Patel, MD, PhD

June 12th 2026

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

ByJason Bartock, MD,Adam Green, MD,Raquel Nahra, MD,Amy Bordogna, MD,Amir Davoodi, MD,Jean-Sebastien Rachoin, MD

June 11th 2026

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

ByDana R. Fletcher, PhD,Lisa M. Sandy, MA,Joy Waughtal, MPH,Cole Hoffman, MS,Sylvie Novins-Montague, BA,Patrick Hosokawa, MS,Pamela N. Peterson, MD, MSPH,Larry A. Allen, MD, MPH,Sheana Bull, PhD,P. Michael Ho, MD, PhD

June 10th 2026

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

ByRazanne Oueini, PharmD,Ben Shirley, BS,Christie Teigland, PhD,Melissa Castora-Binkley, PhD, MA,Scott Bilder, PhD,Kiran Sunkari, MS,Lynn Pezzullo, RPh

June 8th 2026

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

The Impact of Angiotensin-Converting Enzyme Inhibitors on Managed Care: Economic, Clinical, and Humanistic Outcomes (Quiz)

Articles in this issue

Related Content

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Trending on AJMC

FDA Approves Sacituzumab Govitecan-hziy for First-Line Metastatic Triple-Negative Breast Cancer

Treatment Burden, End-of-Life Symptom Gaps in Multiple Myeloma

CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes

ATTR-CM Incidence, Prevalence Rose Sharply in the US

Health Equity & Access Weekly Roundup: June 26, 2026